Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,115,000 | 3,928,000 | 2,184,000 | 5,971,000 | 5,558,000 |
| Depreciation Amortization | 1,140,000 | 753,000 | 373,000 | 1,393,000 | 995,000 |
| Income taxes - deferred | 43,000 | -226,000 | -174,000 | -374,000 | -258,000 |
| Accounts receivable | -3,282,000 | -4,097,000 | -3,174,000 | -683,000 | -490,000 |
| Accounts payable and accrued liabilities | -873,000 | 387,000 | 600,000 | -1,840,000 | -1,812,000 |
| Other Working Capital | -2,753,000 | -2,003,000 | -1,785,000 | -1,719,000 | -1,701,000 |
| Other Operating Activity | 4,816,000 | 4,329,000 | 2,993,000 | 3,060,000 | 2,810,000 |
| Operating Cash Flow | $4,206,000 | $3,071,000 | $1,017,000 | $5,808,000 | $5,102,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -576,000 | -466,000 | -290,000 | 73,000 | -160,000 |
| PPE Investments | -823,000 | -463,000 | -196,000 | -1,256,000 | -934,000 |
| Net Acquisitions | 55,000 | 54,000 | 4,000 | -4,446,000 | -725,000 |
| Purchase Of Investment | -12,265,000 | -8,102,000 | -3,964,000 | -17,986,000 | -14,706,000 |
| Sale Of Investment | 11,853,000 | 8,431,000 | 4,574,000 | 18,572,000 | 13,092,000 |
| Other Investing Activity | -52,000 | -38,000 | -25,000 | -124,000 | -96,000 |
| Investing Cash Flow | $-1,808,000 | $-584,000 | $103,000 | $-5,167,000 | $-3,529,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,643,000 | 1,097,000 | 836,000 | -438,000 | 196,000 |
| Debt Issued | 2,994,000 | 0 | N/A | 7,710,000 | 2,580,000 |
| Debt Repayment | -2,150,000 | -1,250,000 | -1,250,000 | -1,650,000 | -800,000 |
| Common Stock Issued | 21,000 | 21,000 | 23,000 | 221,000 | 205,000 |
| Common Stock Repurchased | -2,134,000 | -1,258,000 | -880,000 | -2,900,000 | -1,089,000 |
| Dividend Paid | -1,152,000 | -771,000 | -386,000 | -1,508,000 | -1,135,000 |
| Other Financing Activity | -1,196,000 | -56,000 | -252,000 | -242,000 | -172,000 |
| Financing Cash Flow | $-1,974,000 | $-2,217,000 | $-1,909,000 | $1,193,000 | $-215,000 |
| Exchange Rate Effect | 1,000 | 2,000 | 1,000 | -6,000 | 2,000 |
| Beginning Cash Position | 8,288,000 | 8,288,000 | 8,288,000 | 6,460,000 | 6,506,000 |
| End Cash Position | 8,713,000 | 8,560,000 | 7,500,000 | 8,288,000 | 7,866,000 |
| Net Cash Flow | $425,000 | $272,000 | $-788,000 | $1,828,000 | $1,360,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,206,000 | 3,071,000 | 1,017,000 | 5,808,000 | 5,102,000 |
| Capital Expenditure | -823,000 | -463,000 | -196,000 | -1,256,000 | -934,000 |
| Free Cash Flow | 3,383,000 | 2,608,000 | 821,000 | 4,552,000 | 4,168,000 |